186 related articles for article (PubMed ID: 22924454)
1. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes.
Kersten H; Molden E; Willumsen T; Engedal K; Bruun Wyller T
Br J Clin Pharmacol; 2013 Mar; 75(3):842-9. PubMed ID: 22924454
[TBL] [Abstract][Full Text] [Related]
2. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial.
Kersten H; Molden E; Tolo IK; Skovlund E; Engedal K; Wyller TB
J Gerontol A Biol Sci Med Sci; 2013 Mar; 68(3):271-8. PubMed ID: 22982689
[TBL] [Abstract][Full Text] [Related]
3. Association between inherited CYP2D6/2C19 phenotypes and anticholinergic measures in elderly patients using anticholinergic drugs.
Kersten H; Wyller TB; Molden E
Ther Drug Monit; 2014 Feb; 36(1):125-30. PubMed ID: 24089073
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.
Chatterjee S; Mehta S; Sherer JT; Aparasu RR
Drugs Aging; 2010 Dec; 27(12):987-97. PubMed ID: 21087068
[TBL] [Abstract][Full Text] [Related]
6. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
[TBL] [Abstract][Full Text] [Related]
7. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
Novella A; Elli C; Ianes A; Pasina L
Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home.
Landi F; Dell'Aquila G; Collamati A; Martone AM; Zuliani G; Gasperini B; Eusebi P; Lattanzio F; Cherubini A
J Am Med Dir Assoc; 2014; 15(11):825-9. PubMed ID: 25282629
[TBL] [Abstract][Full Text] [Related]
9. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
[TBL] [Abstract][Full Text] [Related]
10. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.
Sink KM; Thomas J; Xu H; Craig B; Kritchevsky S; Sands LP
J Am Geriatr Soc; 2008 May; 56(5):847-53. PubMed ID: 18384584
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression.
Chatterjee S; Bali V; Carnahan RM; Chen H; Johnson ML; Aparasu RR
Res Social Adm Pharm; 2020 Mar; 16(3):329-335. PubMed ID: 31182419
[TBL] [Abstract][Full Text] [Related]
12. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
[TBL] [Abstract][Full Text] [Related]
13. [The Effect of Patient Age on Anticholinergic Use in the Elderly Japanese Population -Differences between Four Anticholinergic Scales].
Kimura T; Kato D; Nishimura T; Van Schyndle J; Uno S; Yoshida M
Yakugaku Zasshi; 2020; 140(5):701-710. PubMed ID: 32378674
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study.
Krüger C; Schäfer I; van den Bussche H; Bickel H; Fuchs A; Gensichen J; König HH; Maier W; Mergenthal K; Riedel-Heller SG; Schön G; Weyerer S; Wiese B; von Renteln-Kruse W; Langebrake C; Scherer M
BMJ Open; 2021 Mar; 11(3):e044230. PubMed ID: 33757948
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.
Konishi K; Hori K; Uchida H; Watanabe K; Tominaga I; Kimura M; Hosoyamada M; Shibasaki T; Kataoka A; Hachisu M
Psychogeriatrics; 2010 Mar; 10(1):34-8. PubMed ID: 20594285
[TBL] [Abstract][Full Text] [Related]
16. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
[TBL] [Abstract][Full Text] [Related]
17. Cognitive burden of anticholinergic medications in psychotic disorders.
Eum S; Hill SK; Rubin LH; Carnahan RM; Reilly JL; Ivleva EI; Keedy SK; Tamminga CA; Pearlson GD; Clementz BA; Gershon ES; Keshavan MS; Keefe RSE; Sweeney JA; Bishop JR
Schizophr Res; 2017 Dec; 190():129-135. PubMed ID: 28390849
[TBL] [Abstract][Full Text] [Related]
18. The effect of anticholinergic burden on cognitive and daily living functions in patients with schizophrenia.
Kim SJ; Jung D; Shim JC; Moon JJ; Jeon DW; Kim YN; Seo YS; Jung SS; Seo BJ; Kim JE
Asian J Psychiatr; 2019 Dec; 46():111-117. PubMed ID: 31654923
[TBL] [Abstract][Full Text] [Related]
19. Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression.
Chatterjee S; Bali V; Carnahan RM; Chen H; Johnson ML; Aparasu RR
Drugs Aging; 2017 Sep; 34(9):691-700. PubMed ID: 28656508
[TBL] [Abstract][Full Text] [Related]
20. A preliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia.
Kolanowski A; Fick DM; Campbell J; Litaker M; Boustani M
J Am Med Dir Assoc; 2009 May; 10(4):252-7. PubMed ID: 19426941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
